Literature DB >> 6977099

Impaired cell-mediated immunity in lipoid nephrosis.

K Matsumoto, K Osakabe, M Harada, M Hatano.   

Abstract

Cell-mediated immunity (CMI) was evaluated in 26 patients with lipoid nephrosis (LN), 50 patients suffering from chronic diffuse proliferative glomerulonephritis (CGN) without renal sufficiency and 24 healthy controls. The following parameters were measured: delayed hypersensitivity skin test responses to purified protein derivative (PPD) and candida, circulating lymphocytes. T lymphocytes and T lymphocytes with receptors for the Fc portion of IgG (T gamma cells) or IgM (Tmu cells). Patients with LN in relapse had less mean induration of skin reactivity and a smaller proportion reacting to both antigens as compared with the control subjects. In contrast, the intensity of skin reactivity and the frequency of negative reactions in patients with LN in remission and CGN were similar to those of the control subjects. It was also found that the LN patients in relapse had a significant T lymphocytopenia as well as a significant decrease in absolute numbers of Tmu and T gamma cells, whereas the patients with LN in remission and CGN did not differ significantly from the control population. Thus, the majority of patients with LN in relapse demonstrated an impaired response in a CMI assay system. The disturbed CMI may be secondary to hypoproteinemia and other nutritional factors induced by the nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6977099     DOI: 10.1159/000182357

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  6 in total

Review 1.  The immune system in minimal change nephrotic syndrome.

Authors:  H W Schnaper
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

2.  Lymphocyte adenosine deaminase activity in children with idiopathic nephrotic syndrome.

Authors:  Om P Mishra; Jayant Ghosh; Ziledar Ali; Malay Sen; Rajniti Prasad
Journal:  Pediatr Nephrol       Date:  2005-08-13       Impact factor: 3.714

3.  Serum and urine soluble interleukin-2 receptor in idiopathic nephrotic syndrome.

Authors:  G H Bock; J R Ongkingco; L T Patterson; J Ruley; L R Schroepfer; D L Nelson
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

4.  Impact of tuberculosis in children with idiopathic nephrotic syndrome.

Authors:  U Kala; L S Milner; D Jacobs; P D Thomson
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

5.  Cyclosporin A in steroid-sensitive nephrotic syndrome with frequent relapses.

Authors:  M K Chan; I K Cheng
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

6.  Immunoregulatory treatment for minimal change nephrotic syndrome.

Authors:  K P Mehta; U Ali; M Kutty; U Kolhatkar
Journal:  Arch Dis Child       Date:  1986-02       Impact factor: 3.791

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.